PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHallucinations
MeSH D006212 - hallucinations
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010468:Perceptual disorders
0 Companies
0 Drugs
Success rate
D006212: 
Hallucinations
$
Success rate
D000075562:Charles bonnet syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Acadia PharmaceuticalsPimavanserin Nuplazid 2022-07-27 2016-04-29   
Clinical Trials
Historical Success Rate
Phase 1
0%
0/2
Phase 2
0%
0/3
Phase 3
20%
1/5
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Acadia Pharmaceuticals
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use